Search results
Found 3 matches for
NDORMS has renewed its Athena SWAN Silver Award status in recognition of our commitment to advancing equality and excellence in employment and education practices.
NDORMS researchers awarded for Dupuytren research
Awards Hand Kennedy Main
8 April 2021
Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.
Is surgical repair the best treatment for injuries to the nerves in fingers?
Botnar Hand Main OCTRU SITU
20 November 2019
A new trial, funded by a £1.2 million National Institute of Health Research grant, will explore whether surgery is the best treatment for digital nerve injury.
NDORMS team awarded the International Dupuytren Award
Awards Hand Kennedy Main OCTRU
12 November 2019
Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.
Read our Athena SWAN application
Find out about our family-friendly policies
In NDORMS we actively promote a culture that supports a work–life balance and family friendly work ethic, where both men and women appreciate and value a flexible workplace. It is our intention to allow all of our staff to lead a balanced and fulfilling life.
Find out more about
Similar stories
Clinical trial finds Azithromycin has no benefit against COVID-19
6 May 2021
A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.
Study reveals the three most important aspects of care for hip fractures
5 May 2021
Hip Main OCTRU Research Trauma
Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.
Major ERC funding awarded to Professor Michael Dustin
4 May 2021
Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19
30 April 2021
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
Professor Michael Dustin elected to the National Academy of Sciences
29 April 2021
Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.
Small mechanical forces in immune cells measured at unprecedented sensitivity
16 April 2021
Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.